Edition:
United Kingdom

People: Sawai Pharmaceutical Co Ltd (4555.T)

4555.T on Tokyo Stock Exchange

5,850JPY
19 Apr 2019
Change (% chg)

¥-20 (-0.34%)
Prev Close
¥5,870
Open
¥5,880
Day's High
¥5,900
Day's Low
¥5,820
Volume
113,900
Avg. Vol
202,992
52-wk High
¥6,660
52-wk Low
¥4,570

Sawai, Kenzo 

Mr. Kenzo Sawai has been serving as Senior Managing Executive Officer, Director of Strategy Planning and Director in Sawai Pharmaceutical Co., Ltd., as well as President and Director in a subsidiary, Sawai America Inc., since June 27, 2017. He is also serving as Chairman of the Board in Upsher-Smith,Laboratories,LLC. He joined the Company in April 2001. His previous titles include Manager of Planning Group and Manager of Marketing Group in the Company. He used to work for a company that is under the new name Dainippon Sumitomo Pharma Co., Ltd.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --